GO:0180064 protein O-linked glycosylation via xylose: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0180064 describes a glycoprotein biosynthetic process that begins with the covalent attachment of xylose via a beta-glycosidic bond to the hydroxyl oxygen of serine or threonine residues in a protein.
• This O-linked xylosylation can be further elongated by sequential addition of sugar units, forming a protein O-linked glycan.
• The process is distinct from other O-glycosylation types such as O-glucosylation, which modifies EGF repeats and regulates Notch signaling.
• Xylose-based O-linked glycans have been identified in recombinant therapeutic proteins, where they can affect product homogeneity and function.
• Studying this modification requires specialized methods including mass spectrometry, glycan analysis, and site-directed mutagenesis.
• CRISPR-based models (knockout, knock-in, point mutation) enable causal interrogation of genes involved in xylose O-glycosylation.
Description
Protein O-linked glycosylation via xylose (GO:0180064) is a specialized post-translational modification in which a xylose molecule is covalently attached to the hydroxyl group of serine or threonine residues in a protein via a beta-glycosidic bond. This initial step can be followed by the sequential addition of other sugar units, leading to the formation of a mature O-linked glycan. The term is a child of the broader biological process of protein O-linked glycosylation and is specifically defined by the use of xylose as the first sugar. Understanding this process is important because O-linked glycans influence protein folding, stability, and interactions, and their dysregulation has been linked to various pathologies. For researchers, GO:0180064 provides a precise annotation for genes and pathways involved in xylose-based glycosylation, enabling focused studies on its enzymology and biological roles.
protein O-linked glycosylation via xylose At A Glance
| GO ID | GO:0180064 |
|---|---|
| GO term | protein O-linked glycosylation via xylose |
| Ontology | biological_process |
| Synonym | protein O-linked xylosylation |
| Major function | Covalent attachment of xylose to serine/threonine residues, followed by glycan elongation |
| Parent term | protein O-linked glycosylation |
| Related process | glycoprotein biosynthetic process |
| Key modification | Beta-glycosidic bond to serine/threonine hydroxyl |
What Is GO:0180064?
According to the Gene Ontology, GO:0180064 (protein O-linked glycosylation via xylose) is defined as a glycoprotein biosynthetic process that starts with the covalent linkage of a xylose via a beta-glycosidic bond to the oxygen atom of a serine or threonine side chain in a protein, which can be further elongated with the sequential addition of sugar units resulting in the formation of a protein O-linked glycan. The synonym protein O-linked xylosylation captures the initial step of this process.
Why Is protein O-linked glycosylation via xylose Important in Cell Biology?
Protein O-linked glycosylation via xylose is important because it represents a specific and conserved mechanism for modifying protein function and stability. This modification can influence protein-protein interactions, ligand-receptor signaling, and immune recognition. In biotechnology, xylose-based O-linked glycans on recombinant proteins can impact product quality and efficacy, as seen in lecithin-cholesterol acyltransferase Fc fusion proteins where a xylose-based tetrasaccharide core was identified and eliminated. Thus, understanding GO:0180064 is crucial for both basic biology and therapeutic development.
• Modulates protein structure and function through covalent glycan attachment.
• Plays a role in cell-cell communication and signaling, as exemplified by O-glycosylation in Notch receptors.
• Affects the immunogenicity and half-life of therapeutic glycoproteins.
• Contributes to the biosynthesis of proteoglycans such as decorin and glypican, which are involved in matrix organization and growth factor signaling.
• May be involved in allergic responses, as glycan structures can influence immune recognition.
• Provides a target for glycoengineering to improve recombinant protein drugs.
• Its dysregulation could contribute to diseases such as cancer and fibrosis, though direct evidence for xylose-specific O-glycosylation is still emerging.
• Enables the study of glycosyltransferase specificity and function through CRISPR screens.
What Happens During protein O-linked glycosylation via xylose?
Initiation: Xylose Transfer to Serine/Threonine
In simple terms: A sugar called xylose is attached to a protein at specific spots.
The process begins with the covalent linkage of a xylose molecule via a beta-glycosidic bond to the oxygen atom of a serine or threonine side chain in a target protein. This reaction is catalyzed by a xylosyltransferase enzyme, which transfers xylose from a UDP-xylose donor to the protein acceptor. The specific serine or threonine residues are often found in consensus sequences, though the exact determinants vary among proteins.
Elongation: Sequential Addition of Sugar Units
In simple terms: More sugars are added one by one to build a chain.
Following the initial xylose attachment, the glycan can be further elongated by the sequential addition of other sugar units, such as galactose, glucuronic acid, and others, resulting in the formation of a mature O-linked glycan. This elongation is carried out by a series of glycosyltransferases, each specific for a particular sugar and linkage. The final glycan structure can vary depending on the cell type and the protein substrate.
Substrate Specificity and Protein Targets
In simple terms: Only certain proteins get this sugar modification.
Not all proteins are substrates for O-linked xylosylation. The modification typically occurs on proteins that contain specific serine/threonine-rich regions or particular structural motifs. For example, in recombinant lecithin-cholesterol acyltransferase Fc fusion protein, a xylose-based O-linked tetrasaccharide core was identified in the linker region, highlighting that even engineered proteins can be targets. The specificity is determined by the recognition of the protein substrate by the initiating xylosyltransferase.
Biological Consequences of the Modification
In simple terms: The sugar chain changes how the protein works.
The addition of O-linked xylose and its elongated glycans can affect protein folding, stability, and interactions with other molecules. In some cases, these glycans mediate cell-cell or cell-matrix interactions, as seen in proteoglycans like decorin and glypican. Additionally, the presence of xylose-based glycans on therapeutic proteins can influence their pharmacokinetics and immunogenicity. Thus, this modification has significant functional consequences.
Key Genes Involved in GO:0180064 protein O-linked glycosylation via xylose
The following genes and proteins are known to be involved in or related to protein O-linked glycosylation via xylose, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XYLT1 | Xylosyltransferase 1; initiates O-xylosylation in proteoglycans | Key enzyme for xylose transfer; knockout models affect glycosaminoglycan biosynthesis |
| XYLT2 | Xylosyltransferase 2; initiates O-xylosylation in proteoglycans | Functional redundancy with XYLT1; double knockout is lethal |
| B4GALT7 | Beta-1,4-galactosyltransferase 7; elongates xylose in proteoglycans | Mutations cause Ehlers-Danlos syndrome; relevant for glycan elongation |
| B3GALT6 | Beta-1,3-galactosyltransferase 6; elongates xylose | Involved in linker region synthesis; mutations cause connective tissue disorders |
| B3GAT3 | Beta-1,3-glucuronyltransferase 3; adds glucuronic acid to xylose | Critical for proteoglycan linker completion |
| POGLUT1 | Protein O-glucosyltransferase 1; modifies EGF repeats | Related O-glycosylation; regulates Notch signaling |
| POGLUT2 | Protein O-glucosyltransferase 2; modifies EGF repeats | Similar to POGLUT1; potential crosstalk with xylose pathways |
| POGLUT3 | Protein O-glucosyltransferase 3; modifies EGF repeats | Emerging role in O-glycosylation |
| NOTCH1 | Notch receptor 1; subject to O-glycosylation | O-glucose elongation on EGF repeats regulates ligand binding |
| DLL1 | Delta-like canonical Notch ligand 1; regulated by O-glycosylation | O-glucose modification affects DLL1-NOTCH1 signaling |
| DLL4 | Delta-like canonical Notch ligand 4; regulated by O-glycosylation | Similar to DLL1; O-glycosylation modulates activity |
| LCAT | Lecithin-cholesterol acyltransferase; carries xylose-based O-glycan | Recombinant LCAT-Fc fusion had xylose O-glycan in linker |
| DCN | Decorin; proteoglycan with O-xylosylated glycosaminoglycan chains | Model for studying xylose O-glycosylation in matrix |
| GPC1 | Glypican 1; proteoglycan with O-xylosylated chains | Cell surface proteoglycan involved in signaling |
| EXT1 | Exostosin glycosyltransferase 1; elongates heparan sulfate chains | Downstream of xylose initiation |
| EXT2 | Exostosin glycosyltransferase 2; elongates heparan sulfate chains | Similar to EXT1; mutations cause hereditary multiple exostoses |
| CSGALNACT1 | Chondroitin sulfate N-acetylgalactosaminyltransferase 1; elongates chondroitin sulfate | Adds GalNAc to xylose linker |
| CSGALNACT2 | Chondroitin sulfate N-acetylgalactosaminyltransferase 2; elongates chondroitin sulfate | Similar to CSGALNACT1 |
How Is protein O-linked glycosylation via xylose Regulated?
The regulation of protein O-linked glycosylation via xylose is not fully understood, but it likely involves the expression levels and activities of xylosyltransferases and downstream glycosyltransferases. These enzymes are regulated transcriptionally and post-translationally, and their activity can be influenced by the availability of nucleotide sugar donors such as UDP-xylose. Additionally, the process may be modulated by cellular stress and signaling pathways, as seen with other O-glycosylation types. However, specific regulatory mechanisms for GO:0180064 remain to be elucidated.
protein O-linked glycosylation via xylose and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| B4GALT7 | Ehlers-Danlos syndrome, spondylodysplastic type | Knockout in fibroblasts; point mutation knock-in in mice |
| B3GALT6 | Ehlers-Danlos syndrome, spondylodysplastic type | CRISPR knockout in chondrocytes; overexpression of mutant |
| XYLT1 | Desbuquois dysplasia | Knockout mouse model; patient-derived iPSCs |
| XYLT2 | Spondylocular syndrome | Knockout zebrafish; knock-in of patient mutations |
| LCAT | Fish-eye disease, corneal opacities | Recombinant LCAT-Fc with xylose glycan; site-directed mutagenesis |
Connective Tissue Disorders
Defects in the xylose-based O-glycosylation pathway can lead to connective tissue disorders. For example, mutations in B4GALT7 and B3GALT6, which are involved in elongating the xylose linker in proteoglycans, cause Ehlers-Danlos syndrome-like phenotypes. These disorders highlight the importance of O-linked xylosylation in extracellular matrix integrity.
Cancer and Signaling
Altered glycosylation, including O-linked modifications, is a hallmark of cancer. While direct evidence for xylose-specific O-glycosylation in cancer is limited, related O-glycosylation pathways such as O-glucosylation of Notch receptors regulate signaling pathways that are frequently dysregulated in cancer. Thus, understanding GO:0180064 may provide insights into cancer biology.
Therapeutic Protein Immunogenicity
Xylose-based O-linked glycans on recombinant therapeutic proteins can affect their immunogenicity and clearance. In a recombinant human lecithin-cholesterol acyltransferase Fc fusion protein, a xylose-based O-linked tetrasaccharide core was identified in the linker region, and its elimination was pursued to improve product homogeneity. This underscores the clinical relevance of this modification.
From protein O-linked glycosylation via xylose-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of XYLT1 abolish O-xylosylation? | CRISPR knockout in HEK293T cells |
| What is the effect of a specific point mutation in B4GALT7 on glycan elongation? | Point mutation knock-in via CRISPR in patient fibroblasts |
| Can we tag the xylosyltransferase to track its localization? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of B3GAT3 increase xylose-based glycan levels? | Overexpression via lentiviral transduction |
| Which genes are essential for O-linked xylosylation? | Genome-wide CRISPR knockout library screening |
| How does the xylose O-glycan affect protein function? | Knock-in of glycosylation site mutants (Ser/Thr to Ala) |
How to Study the protein O-linked glycosylation via xylose Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Glycan structure and attachment site | Characterization of O-linked xylose on recombinant proteins |
| Lectin blotting | Presence of xylose-containing glycans | Screening for glycosylation mutants |
| In vitro glycosyltransferase assay | Enzyme activity and substrate specificity | Functional analysis of XYLT1/2 |
| CRISPR knockout screen | Genes essential for O-xylosylation | Discovery of novel pathway components |
| Site-directed mutagenesis | Effect of removing specific glycosylation sites | Functional studies of target proteins |
| Flow cytometry | Cell surface glycan expression | Analysis of proteoglycans like glypican |
| Immunoprecipitation | Protein-glycan interactions | Isolation of xylosylated proteins |
| Glycan array | Binding specificity of glycan-binding proteins | Studying lectin interactions |
Mass Spectrometry for Glycan Analysis
Mass spectrometry (MS) is a key method to identify and characterize O-linked xylose glycans on proteins. Techniques such as LC-MS/MS can determine the site of attachment and the structure of the glycan. For example, MS was used to identify a xylose-based O-linked tetrasaccharide core in a recombinant LCAT-Fc fusion protein.
Glycosyltransferase Activity Assays
In vitro enzyme assays using recombinant xylosyltransferases and acceptor peptides can measure the transfer of xylose from UDP-xylose to serine/threonine residues. These assays help define substrate specificity and kinetics.
CRISPR Screening for Pathway Genes
Genome-wide CRISPR knockout screens can identify genes required for O-linked xylosylation. By using a lectin or antibody that recognizes xylose-based glycans, researchers can select for cells with disrupted glycosylation and identify candidate genes.
Site-Directed Mutagenesis and Knock-in Models
To study the function of specific glycosylation sites, serine/threonine residues can be mutated to alanine using CRISPR-based knock-in. This approach ablates the glycan attachment and allows assessment of functional consequences.
How CRISPR Can Be Used to Study GO:0180064 protein O-linked glycosylation via xylose
Knockout
CRISPR knockout of genes involved in O-linked xylosylation, such as XYLT1 or XYLT2, can completely abolish the modification. This is useful to study the loss-of-function phenotypes, such as defects in proteoglycan biosynthesis and extracellular matrix assembly. Knockout cell lines can be generated in various cell types, including HEK293T and fibroblasts.
Point Mutation
Point mutations in glycosyltransferase genes can be introduced using CRISPR base editing or homology-directed repair to model human diseases. For example, specific mutations in B4GALT7 found in Ehlers-Danlos syndrome can be recapitulated in cell lines to study the impact on xylose glycan elongation.
Knock-in
Knock-in of tags (e.g., FLAG, GFP) at the endogenous locus of xylosyltransferases allows for real-time tracking of protein localization and interaction. Additionally, knock-in of glycosylation site mutations (Ser/Thr to Ala) in target proteins can specifically ablate O-xylosylation and reveal its function.
Overexpression
Overexpression of xylosyltransferases or downstream glycosyltransferases via CRISPR activation (CRISPRa) or lentiviral delivery can increase O-linked xylose levels. This is useful to study the effects of enhanced glycosylation on protein function and cell behavior.
How EDITGENE Supports protein O-linked glycosylation via xylose Research
Researchers studying protein O-linked glycosylation via xylose-related genes often need to determine whether a candidate gene is causally involved in the modification and its downstream biology. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for protein O-linked glycosylation via xylose research.
Frequently Asked Questions About protein O-linked glycosylation via xylose
What is protein O-linked glycosylation via xylose?
It is a biological process (GO:0180064) where a xylose sugar is attached to serine or threonine residues on proteins, potentially followed by elongation with other sugars.
What genes are involved in protein O-linked glycosylation via xylose?
Key genes include XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3, which encode enzymes that initiate and elongate the xylose-based glycan.
What is the function of O-linked xylose on proteins?
It can affect protein stability, interactions, and signaling, and is important for proteoglycan biosynthesis and extracellular matrix function.
How is protein O-linked glycosylation via xylose studied?
Methods include mass spectrometry, lectin blotting, glycosyltransferase assays, and CRISPR screens.
What diseases are associated with defects in O-linked xylosylation?
Mutations in genes like B4GALT7 and B3GALT6 cause connective tissue disorders such as Ehlers-Danlos syndrome.
Can CRISPR be used to study O-linked xylosylation?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to dissect gene function in this pathway.
What is the difference between O-linked xylosylation and O-glucosylation?
O-xylosylation attaches xylose to serine/threonine, while O-glucosylation attaches glucose to serine residues in EGF repeats, as seen in Notch signaling.
Is O-linked xylosylation reversible?
Currently, no enzymes have been identified that remove xylose from O-linked glycans, so it is considered irreversible.
What is the role of xylose O-glycans in therapeutic proteins?
They can affect product homogeneity and immunogenicity, as seen in recombinant LCAT-Fc where a xylose-based glycan was eliminated.
How can I model O-linked xylosylation defects in the lab?
You can use CRISPR to knock out or mutate glycosyltransferase genes in cell lines, or use patient-derived cells with known mutations.
Conclusion
Protein O-linked glycosylation via xylose (GO:0180064) is a specific and biologically significant post-translational modification that influences protein function and extracellular matrix biology. Its study is facilitated by advances in CRISPR genome editing and glycomics, which enable precise interrogation of the involved genes and pathways. Understanding this process has implications for connective tissue disorders, cancer, and the development of therapeutic glycoproteins.
References
- 1. Álvarez J et al.. 2025. Correlation Between N-Glycan GnGnXF3 and the Allergic Immune Response Against Juniperus ashei Pollen.. Allergy 80(7):1935-1944 PMID: 39912313
- 2. Mehboob MZ et al.. 2021. Structure, function, and pathology of protein O-glucosyltransferases.. Cell Death Dis 12(1):71 PMID: 33436558
- 3. Tsukamoto Y et al.. 2025. Differential O-glucose elongation on a specific EGF repeat within the canonical ligand-binding domain regulates DLL1/4-NOTCH1 signaling.. Proc Natl Acad Sci U S A 122(43):e2504827122 PMID: 41129232
- 4. Peter-Katalinić J. 2005. Methods in enzymology: O-glycosylation of proteins.. Methods Enzymol 405:139-71 PMID: 16413314
- 5. Fransson LA et al.. 2000. Biosynthesis of decorin and glypican.. Matrix Biol 19(4):367-76 PMID: 10963998
- 7. Spahr C et al.. 2013. Recombinant human lecithin-cholesterol acyltransferase Fc fusion: analysis of N- and O-linked glycans and identification and elimination of a xylose-based O-linked tetrasaccharide core in the linker region.. Protein Sci 22(12):1739-53 PMID: 24115046
